Although we did not detect increased levels of this protein in the plasma of our animal model using ELISA, the elevated expression of the ANXA2 gene in the liver and previous clinical evidence suggest that it could be an early HCC biomarker. Here, ANXA2 is linked to hepatocellular carcinoma.